Stock data

易威 (1799)

易威 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$138.46M, up 80.6% from a year earlier. EPS over the last four quarters totals -NT$0.13.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 易威 in Insightr